Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.3663 USD
−5.98 M USD
5.42 M USD
14.84 M
About Biomerica, Inc.
Sector
Industry
CEO
Zackary S. Irani
Website
Headquarters
Irvine
Founded
1971
FIGI
BBG000BDH8F6
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BMRA is 0.3250 USD — it has increased by 2.21% in the past 24 hours. Watch Biomerica, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Biomerica, Inc. stocks are traded under the ticker BMRA.
BMRA stock has fallen by −10.32% compared to the previous week, the month change is a −11.46% fall, over the last year Biomerica, Inc. has showed a −72.92% decrease.
BMRA reached its all-time high on Nov 12, 1980 with the price of 24.3335 USD, and its all-time low was 0.1700 USD and was reached on Jan 6, 2003. View more price dynamics on BMRA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BMRA stock is 20.33% volatile and has beta coefficient of 1.28. Track Biomerica, Inc. stock price on the chart and check out the list of the most volatile stocks — is Biomerica, Inc. there?
Today Biomerica, Inc. has the market capitalization of 4.68 M, it has decreased by −4.47% over the last week.
Yes, you can track Biomerica, Inc. financials in yearly and quarterly reports right on TradingView.
Biomerica, Inc. is going to release the next earnings report on Jan 21, 2025. Keep track of upcoming events with our Earnings Calendar.
BMRA net income for the last quarter is −1.32 M USD, while the quarter before that showed −1.42 M USD of net income which accounts for 7.39% change. Track more Biomerica, Inc. financial stats to get the full picture.
No, BMRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 64.00 employees. See our rating of the largest employees — is Biomerica, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biomerica, Inc. EBITDA is −6.13 M USD, and current EBITDA margin is −110.67%. See more stats in Biomerica, Inc. financial statements.
Like other stocks, BMRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biomerica, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biomerica, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biomerica, Inc. stock shows the sell signal. See more of Biomerica, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.